Chemistry:Zofenopril

From HandWiki
Short description: Antihypertensive drug of the ACE inhibitor class
Zofenopril
Zofenopril structure.svg
Clinical data
Trade namesZocardis (Russia )
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC22H23NO4S2
Molar mass429.55 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Zofenopril (INN) is a medication that protects the heart and helps reduce high blood pressure. It is an angiotensin-converting enzyme (ACE) inhibitor.[1]

In small studies, zofenopril appeared significantly more effective in reducing hypertension than two older antihypertensive drugs, atenolol and enalapril, and was associated with fewer adverse effects.[2][3]

Zofenopril is a prodrug with zofenoprilat as the active metabolite.[4]

It was patented in 1978 and approved for medical use in 2000.[5]

References

  1. "Defining the role of zofenopril in the management of hypertension and ischemic heart disorders". American Journal of Cardiovascular Drugs 7 (1): 17–24. 2007. doi:10.2165/00129784-200707010-00002. PMID 17355163. 
  2. "Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension". Blood Pressure. Supplement 2: 25–30. October 2007. doi:10.1080/08038020701561745. PMID 18046976. 
  3. "An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension". Blood Pressure. Supplement 2: 13–18. October 2007. doi:10.1080/08038020701561703. PMID 18046974. 
  4. "Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties". Cardiovascular Drug Reviews 17 (2): 115–133. 1999. doi:10.1111/j.1527-3466.1999.tb00008.x. 
  5. (in en) Analogue-based Drug Discovery. John Wiley & Sons. 2006. p. 467. ISBN 978-3-527-60749-5. https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA467.